It is very uncertain whether benzodiazepines (lorazepam) changes mortality from all causes compared with antipsychotics (haloperidol) (very low certainty).

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
RR 1.83 [0.34, 9.92]
1 study · 17 participants
Very low

Benzodiazepines (lorazepam) vs placebo

Severity of delirium · end‐of‐life patients with advanced cancer and an episode of agitated delirium

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Low

Benzodiazepines (lorazepam) vs placebo

Any adverse event · end‐of‐life patients with advanced cancer and an episode of agitated delirium

The review found no eligible studies for this question.

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Benzodiazepines (lorazepam) vs placebo

Length of hospital stay · end‐of‐life patients with advanced cancer and an episode of agitated delirium

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Benzodiazepines (lorazepam) vs placebo

Mortality from all causes · end‐of‐life patients with advanced cancer and an episode of agitated delirium

Benzodiazepines (lorazepam) showed no clear difference in mortality from all causes compared with placebo (low certainty).

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
RR 0.33 [0.04, 3.02]
1 study · 58 participants
Low

Benzodiazepines (lorazepam) vs chlorpromazine

Length of delirium episode · adult AIDS patients with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Benzodiazepines (lorazepam) vs chlorpromazine

Severity of delirium · adult AIDS patients with delirium

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Very low

Benzodiazepines (lorazepam) vs chlorpromazine

Any adverse event ESRS, higher = worse · adult AIDS patients with delirium

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Very low

Benzodiazepines (lorazepam) vs chlorpromazine

Duration of hospital admission (days) · adult AIDS patients with delirium

The review found no eligible studies for this question.

1 finding from 1 review

Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Mortality at longest · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…

It is very uncertain whether the intervention changes mortality at longest (very low certainty).

1 finding from 1 review

Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
OR 1.83 [1.03, 3.27]
1 study · 201 participants
Very low

Intervention not reported

Number of days ventilated · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…

1 finding from 1 review

Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 201 participants
Very low

Intervention not reported

Requirement for inotropic support (scale from 0 to 28, days of catecholamine use) · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…

1 finding from 1 review

Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 201 participants
Very low

Intervention not reported

Requirement for renal replacement therapy ( · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…

It is very uncertain whether the intervention changes requirement for renal replacement therapy ( (very low certainty).

1 finding from 1 review

Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
OR 1.03 [0.41, 2.6]
1 study · 201 participants
Very low

Intervention not reported

Quality of life · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…

1 finding from 1 review

Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a… 2020 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported

Intervention not reported

Adaptive behavior Measured by: Vineland Adaptive Behavior Scales (parent‐reported scale; mean = 100 (SD = 15); higher score equates to better outcomes) · patients with young children (less than six years old) with autism spectrum disorders (ASD)

1 finding from 1 review

Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD) 2018 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 202 participants
Low

Intervention not reported

Autism symptom severity Measured by: parent‐reported autism symptoms on standardised autism screening and diagnostic instruments (lower scores indicate less severe autism symptoms) · patients with young children (less than six years old) with autism spectrum disorders (ASD)

1 finding from 1 review

Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD) 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 81 participants
Very low

Intervention not reported

Adverse effects Measured by: worsening of adaptive behavior or autism symptom severity · patients with young children (less than six years old) with autism spectrum disorders (ASD)

The review found no eligible studies for this question.

1 finding from 1 review

Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD) 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found